Literature DB >> 11580993

Polymorphism of the polyalanine tract of thyroid transcription factor-2 gene in patients with thyroid dysgenesis.

A Hishinuma1, Y Ohyama, T Kuribayashi, N Nagakubo, T Namatame, K Shibayama, O Arisaka, N Matsuura, T Ieiri.   

Abstract

OBJECTIVE: One of the thyroid-specific transcription factors, thyroid transcription factor-2 (TTF-2), performs a crucial role in the development of the thyroid gland. We performed genetic analysis of the TITF2 gene (encoding TTF-2) in patients with thyroid dysgenesis.
METHODS: By direct sequencing of the PCR products of TITF2, we screened the genomic DNA from 46 patients with thyroid dysgenesis (five had agenesis, six had hypoplasia, 15 had ectopy, and 20 were undetermined). We also studied the transcriptional activities of TITF2 by co-expressing the luciferase gene directed by the human thyroglobulin gene promoter.
RESULTS: Human TITF2 consists of a forkhead domain, a polyalanine tract, and unique C-terminal residues. In one of the patients with an ectopic sublingual thyroid, we found a polyalanine tract of 11 alanine residues on one chromosome instead of the 14 alanine residues found in normal controls. In one patient with hypoplasia, the polyalanine tract consisted of 12 heterozygous alanine residues. The reduced polyalanine tracts were not detected in 101 normal individuals. However, the expression study showed that the transcriptional activities of TITF2 with reduced polyalanine-tract lengths were equal to that of TITF2 with an unreduced polyalanine tract.
CONCLUSION: These results suggest that the polymorphism of the polyalanine tract of TITF2 is not a frequent cause of developmental defects of the human thyroid gland.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580993     DOI: 10.1530/eje.0.1450385

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  A genomic basis for the evolution of vertebrate transcription factors containing amino Acid runs.

Authors:  Sandrine Caburet; Daniel Vaiman; Reiner A Veitia
Journal:  Genetics       Date:  2004-08       Impact factor: 4.562

2.  Common genetic variants on FOXE1 contributes to thyroid cancer susceptibility: evidence based on 16 studies.

Authors:  Yixin Zhuang; Weixin Wu; Han Liu; Weixin Shen
Journal:  Tumour Biol       Date:  2014-04-18

Review 3.  Genetics of congenital hypothyroidism.

Authors:  S M Park; V K K Chatterjee
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

4.  TTF-2/FOXE1 gene polymorphisms in Sicilian patients with permanent primary congenital hypothyroidism.

Authors:  L Santarpia; M Valenzise; G Di Pasquale; T Arrigo; G San Martino; M P Cicciò; F Trimarchi; F De Luca; S Benvenga
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

5.  A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1.

Authors:  Andrew C Lidral; Huan Liu; Steven A Bullard; Greg Bonde; Junichiro Machida; Axel Visel; Lina M Moreno Uribe; Xiao Li; Brad Amendt; Robert A Cornell
Journal:  Hum Mol Genet       Date:  2015-02-04       Impact factor: 6.150

6.  Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis.

Authors:  Aurore Carré; Mireille Castanet; Sylvia Sura-Trueba; Gabor Szinnai; Guy Van Vliet; Delphine Trochet; Jeanne Amiel; Juliane Léger; Paul Czernichow; Virginie Scotet; Michel Polak
Journal:  Hum Genet       Date:  2007-08-24       Impact factor: 4.132

7.  FOXE1 polyalanine tract length screening by MLPA in idiopathic premature ovarian failure.

Authors:  Chun-rong Qin; Ji-long Yao; Wen-jie Zhu; Wei-qing Wu; Jian-sheng Xie
Journal:  Reprod Biol Endocrinol       Date:  2011-12-16       Impact factor: 5.211

8.  Does the Polymorphism in the Length of the Polyalanine Tract of FOXE1 Gene Influence the Risk of Thyroid Dysgenesis Occurrence?

Authors:  Clebson Pantoja Pimentel; Erik Artur Cortinhas-Alves; Edivaldo Herculano Correa de Oliveira; Luiz Carlos Santana-da-Silva
Journal:  J Thyroid Res       Date:  2017-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.